NOTA:FRA
Novartis AG
141,00 €
arrow_upward
+2,92%(+4,00) 1 p
3. sept, 22:00:00 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOTA põhistatistika genereerimine…
Ava
137,00 €
Kõrge
141,00 €
Madal
137,00 €
Turu kapit.
330,56 mld
Keskm. maht
47,00
Maht
40,00
52 näd kõrgeim
145,00 €
52 näd madalaim
101,50 €
Töötajate arv
75 tuh
Ava
137,00 €
Kõrge
141,00 €
Madal
137,00 €
Turu kapit.
330,56 mld
Keskm. maht
47,00
Maht
40,00
52 näd kõrgeim
145,00 €
52 näd madalaim
101,50 €
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
9 tunni eest
Novartis stock holds steady as billion-dollar Alteogen deal and MS pill data reshape pipeline
MedWatch
·
13 tunni eest
Novartis to cut 130 jobs as it ends biologics production at Swiss site
Chosunbiz
·
1 päeva eest
Alteogen secures Novartis license option worth up to 4.4 trillion won, shares rise - CHOSUNBIZ
Proactive financial news
·
1 päeva eest
Panmure Liberum says OxfordBiomedica share fall overdone after Novartis and BMS pause trials
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com